首页> 外国专利> Cyclo- (Nuarr; epsi; uarr; -allidin), Nuarr; alpha; uarr; -Arginyl-cyclo - (Nuarr; epsi; uarr; -1-lysine, 6-glycine) bradykinin and Cyclo - (omega; -aminododecanoyl) bradykinin and their use

Cyclo- (Nuarr; epsi; uarr; -allidin), Nuarr; alpha; uarr; -Arginyl-cyclo - (Nuarr; epsi; uarr; -1-lysine, 6-glycine) bradykinin and Cyclo - (omega; -aminododecanoyl) bradykinin and their use

机译:Cyclo-(Nuarr; epsi; uarr; -allidin),Nuarr; α; ua -精氨酸环-[(Nuarr; epsi; uarr; -1-赖氨酸,6-甘氨酸)缓激肽]和Cyclo-[(ω;-氨基十二烷酰基)缓激肽]及其用途

摘要

Novel cyclic analogues of callidine have the following general formula: IMAGE wherein Pro is moiety of L-proline, Gly-that of glycine, Phe-phenylalanine, Arg-L-argenine; R is a residue of alpha - or omega -aminoacid or peptide; R1 is a residue of alpha - or omega - amino-acid; R2 is L-serine or glycine, the carbonyl group of arginine being connected either with R or with R1 by means of a covalent peptide bond using the omega -amino group of the aminoacid located in the 1 or 2 position of the calladine sequence. The novel compounds according to the present invention possess a prolonged hypotensive effect of selective character.
机译:Callidine的新型环状类似物具有以下通式:,其中Pro是L-脯氨酸的部分,甘氨酸是甘氨酸的部分,Phe-苯丙氨酸,Arg-L-精氨酸的部分; R是α-或ω-氨基酸或肽的残基; R1是α-或ω-氨基酸的残基; R 2是L-丝氨酸或甘氨酸,精氨酸的羰基利用位于马蹄苷序列的1或2位的氨基酸的ω-氨基通过共价肽键与R或与R 1连接。根据本发明的新型化合物具有延长的选择性特征的降血压作用。

著录项

相似文献

  • 专利
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号